results Search
Eventi-img

26 Sep 19: Uso Compassionevole, Off Label e Off-Licence dei medicinali

Uso Compassionevole, Off Label e Off-Licence dei medicinali 26 September 2019 Crowne Plaza Milan City (Via Melchiorre Gioia, 73 – 20124, Milano)       PROGRAMMA: Uso compassionevole, Off-label e Off-licence dei medicinali   Speakers Dr.ssa Barbara Capaccetti, Country Medical Director Pfizer Avv. Agostino Migone de Amicis, Presidente, Comitato Etico Ist. Clinico Humanitas Avv. Claudia Pasturenzi, Studio Legale Astolfi e Associati, Milano Dr. Davide Tassinari, Direttore Unità Operativa Oncologia di Rimini

Eventi-img

25 Mar 19: Life Sciences Practice Group – Annual Meeting

LIFE SCIENCES PRACTICE GROUP – ANNUAL MEETING   Program Monday, 25 March 2019 15,00 Inizio lavori 18,30 visita guidata in inglese alla Pietà Rondanini 19,30 Social Dinner Martedì 26 marzo   Panel 1 Status of EU and national legislation in view of the application (if and when) of Regulation 536/2014; impact of related Regulations, particularly GDPR Speakers: Dr. Liliana Burzilleri (Regione Lombardia) Dr. Felice Lopane (Assolombarda) Avv. Deborah Bolco (Pavia e Ansaldo) on GDPR aspects   Panel 2 Pprofit and non-profit approach in clinical trials in the new (Regulation or not) European environment, in the context of a continuing technological…

Sanità_news

07 Feb 19: Veterinary medicines: the new EU Regulation is published

VETERINARY MEDICINES: THE NEW EU REGULATION IS PUBLISHED Milan, 7 February 2019 – After four years from the first regulation proposal on veterinary medicinal products (“VMP”)[1], on 26th November 2018 the Council approved the new Regulation, which has been published on the Official Journal on 7th January 2019 (EU Regulation 2019/6, the “Regulation”). The Regulation repeals Directive 2001/82/EC and shall apply from 28 January 2022. Since the first regulation proposal on this matter, the European Commission has called for an in-depth revision of the internal market of VMP. In particular, the Commission highlighted the need to harmonise the European legal framework,…

Sanità_news

26 Oct 16: Pavia e Ansaldo sponsor of the 5th Healtcare Summit of Il Sole 24 Ore

PAVIA E ANSALDO SPONSOR OF THE 5TH HEALTHCARE SUMMIT OF IL SOLE 24 ORE “FUTURE HEALTHCARE” Agostino Migone De Amicis, partner of Pavia e Ansaldo, participated as speaker on “Research and independent experimentation: hub or … handicap for the development of Italian excellence?” Milan, 26 October 2016 – The 5th Healthcare Summit organized by Il Sole 24 Ore sponsored by, among others, Pavia e Ansaldo took place today in Rome. Agostino Migone De Amicis, partner and head of the Health and Pharmaceutical (Regulatory) Department of Pavia e Ansaldo as well as Chairman of the Ethics Committee of Humanitas, participated as speaker in…

Dip_Mergers

05 Jul 16: Pavia e Ansaldo with Bio-Techne Corporation in the purchase of space Import-Export S.r.l.

Pavia e Ansaldo with Bio-Techne Corporation in the purchase of space Import-Export S.r.l. Milan, 5 July 2016 – Pavia e Ansaldo assisted Bio-Techne Corporation – an American corporation listed on the Nasdaq in New York and active in the life sciences sector – in the purchase, through an English subsidiary of the group, of the entire corporate capital of Space Import-Export Srl, a distributor of products for biomedical research and diagnostic markets. Partner Francesco Manara, coordinated the team acting for Bio-Techne, composed by partner Paola Carlotti with Francesca Bottani and Miriam Hamdan for contractual and corporate aspects, partner Valentina Simonelli for…